Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a range of key areas of expertise.
- Research & Innovation
- Business & Industry
Alumni, Friends & Supporters
Alumni, Friends & Supporters
There are over 90,000 NUI Galway graduates Worldwide, connect with us and tap into the online community.
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
December 2016 Leading expert in cardiology joins NUI Galway to lead €5 million project in medical devices
Leading expert in cardiology joins NUI Galway to lead €5 million project in medical devices
Plan to develop wearable sensors for patients at high risk of heart attacks
Professor William Wijns, an expert in cardiology, has joined NUI Galway as Professor of Medical Devices. He will spearhead a €5 million research project, which will develop wearable sensors to alert patients at high risk of heart attacks to triggers such as stress or high blood pressure.
Professor Wijns joins the University through the Science Foundation Ireland Research Professorship Programme, which supports national strategic priorities by recruiting world-leading research and leadership talent to Ireland.
“The medical technology sector in Ireland is recognised as one of five global emerging hubs,” explains Professor Lokesh Joshi, Vice-President for Research at NUI Galway. “Eight of the world’s top ten med-tech companies are based here, and the West of Ireland in particular is at the heart of the Irish med-tech system. NUI Galway is the powerhouse for much of this progress and we have developed a range of interdisciplinary research centres and initiatives, working closely with partners in industry, healthcare and government agencies. We welcome Professor Wijns with great anticipation of the opportunities his transformative approach brings to the translation of research into practice to ultimately deliver better health outcomes for patients.”
In recent years Professor Wijns has held board memberships in the European Society of Cardiology and the World Heart Federation. He is currently Chairman of PCR, co-Director of Africa PCR and EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions.
Professor Wijns previously worked at the Thorax Center in Rotterdam, where he was actively involved with the first applications of nuclear cardiology, thrombolysis and coronary dilatation, and the University of Louvain in Brussels, where he was Clinical Professor of Cardiology.
At NUI Galway, Professor Wijns’ programme of work will focus on interventional cardiology, more specifically on reducing the number of adverse cardiovascular events (heart attacks) in patients. His focus is consistent with the strategic research goals of the University, the Clinical Research Facility at University Hospital Galway and CÚRAM, the Science Foundation Ireland Centre for Research in Medical Devices, also based at NUI Galway.
“I am extremely delighted to be awarded this Science Foundation Ireland Research Professorship at NUI Galway where there exists excellent facilities and world-class researchers in this field. I am also excited by the potential to further my research and to work with such a strong network of academic, clinical and industrial partners in the course of my appointment,” said Professor Wijns.
Professor Wijns’ research focuses on heart attacks and sudden death caused by unexpected blockage of arteries supplying the heart with blood and oxygen. This occurs in people exposed to risk factors such as family history, hypertension, smoking, diabetes or high cholesterol, who exhibit a vulnerable narrowing in the walls of their arteries, without being aware of it.
Trigger mechanisms like anger, mental stress, high blood pressure, strenuous exercise and sleep disorders cause the narrowing to rupture inside the conduit, obstructing the artery. His work will look at developing medical devices that can monitor these “trigger” activities electronically, at a distance, using wearable sensors in high-risk subjects who are known to carry this vulnerable narrowing of the artery, and in doing so, anticipate and prevent heart attacks.
Professor Mark Ferguson, Director General of Science Foundation Ireland and Chief Scientific Adviser to the Government of Ireland said: “It is with great pleasure that I announce the appointment of Professor Wijns to NUI Galway through the Science Foundation Ireland Research Professorship Programme. Professor Wijns is a world-class researcher dedicated to improving the health and wellbeing of people by the invention and application of new technologies. His appointment epitomises Science Foundation Ireland’s commitment to fund world class research with impact in the health and medtech sector. I believe that great new research advances of real value to people and the economy will result from the combination of Prof Wijns’ expertise, the exceptional research teams in NUI Galway and the CÚRAM SFI Research Centre, and the cluster of both multinational and indigenous Medical Device companies in Ireland.”
Professor Abhay Pandit, Scientific Director of CÚRAM, the Science Foundation Ireland Centre for Research in Medical Devices, said: “The research community here at NUI Galway is delighted to welcome Professor Wijns. We recognise the immense impact that he has had to date in cardiology research and we look forward to future collaborations and to supporting him in his research in the coming years.”
Professor Wijns will also join the Cardiology Department at Saolta University Healthcare group, where he will collaborate with other clinicians engaged in translational cardiovascular research.
Professor Tim O’Brien, Dean of the College of Medicine, Nursing and Health Sciences at NUI Galway, said: “Professor Wijns will enable essential collaborations between investigators at CÚRAM and the Lambe Institute for Translational Research and clinician researchers at the HRB Clinical Research Facility Galway, ensuring that basic research will be translated to new medical devices which will benefit patients globally.”